1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Tissue Processing Systems Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Tissue Processing Systems Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Tissue Processing Systems Market Regional Analysis
6.2 North America Tissue Processing Systems Market Revenue 2017-2027 (US$ Million)
6.3 North America Tissue Processing Systems Market Forecast Analysis
7. North America Tissue Processing Systems Market Analysis – by Product
7.1 Tissue transfer processors
- 7.1.1 Overview
- 7.1.2 Tissue transfer processors: North America Tissue Processing Systems Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Fluid transfer processors
- 7.2.1 Overview
- 7.2.2 Fluid transfer processors: North America Tissue Processing Systems Market – Revenue and Forecast, 2017-2027 (US$ Million)
8. North America Tissue Processing Systems Market Analysis – by Volume
8.1 Small Volume Processors
- 8.1.1 Overview
- 8.1.2 Small Volume Processors: North America Tissue Processing Systems Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 Medium Volume Processors
- 8.2.1 Overview
- 8.2.2 Medium Volume Processors: North America Tissue Processing Systems Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.3 Large volume processors
- 8.3.1 Overview
- 8.3.2 Large volume processors: North America Tissue Processing Systems Market – Revenue and Forecast, 2017-2027 (US$ Million)
9. North America Tissue Processing Systems Market Analysis – by End user
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: North America Tissue Processing Systems Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.2 Pharmaceutical companies
- 9.2.1 Overview
- 9.2.2 Pharmaceutical companies: North America Tissue Processing Systems Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.3 Research laboratories
- 9.3.1 Overview
- 9.3.2 Research laboratories: North America Tissue Processing Systems Market – Revenue and Forecast, 2017-2027 (US$ Million)
10. North America Tissue Processing Systems Market – North America Analysis
10.1 Overview
10.2 North America
- 10.2.1 North America Tissue Processing Systems Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 10.2.1.1 North America Tissue Processing Systems Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 US:
North America Tissue Processing Systems Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.1.1 US: North America Tissue Processing Systems Market Breakdown, by Product
- 10.2.1.1.2 US: North America Tissue Processing Systems Market Breakdown, by Volume
- 10.2.1.1.3 US: North America Tissue Processing Systems Market Breakdown, by End user
- 10.2.1.2 Canada:
North America Tissue Processing Systems Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.2.1 Canada: North America Tissue Processing Systems Market Breakdown, by Product
- 10.2.1.2.2 Canada: North America Tissue Processing Systems Market Breakdown, by Volume
- 10.2.1.2.3 Canada: North America Tissue Processing Systems Market Breakdown, by End user
- 10.2.1.3 Mexico :
North America Tissue Processing Systems Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.3.1 Mexico : North America Tissue Processing Systems Market Breakdown, by Product
- 10.2.1.3.2 Mexico : North America Tissue Processing Systems Market Breakdown, by Volume
- 10.2.1.3.3 Mexico : North America Tissue Processing Systems Market Breakdown, by End user
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Miltenyi Biotec
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 BioGenex
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Leica Biosystems Nussloch GmbH (Danaher)
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Avantor, Inc.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 THERMO FISHER SCIENTIFIC INC.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Siemens AG
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 F. HOFFMANN-LA ROCHE LTD
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Agilent Technologies, Inc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Milestone Medical
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Sakura Finetek USA, Inc.
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations